These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6711082)

  • 1. [Comparison of 2 recent isosorbide dinitrate preparations as new long-term galenicals with commonly used delayed-action preparations].
    Hagel H
    ZFA (Stuttgart); 1984 Jan; 60(1):40-3. PubMed ID: 6711082
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
    Joseph G
    Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
    [No Abstract]   [Full Text] [Related]  

  • 4. [Iso Mack Retard 40 mg. Coronary drug for long term therapy and prophylaxis in coronary circulation disorders (angina pectoris)].
    Wien Klin Wochenschr; 1980 Oct; 92(19):695-6. PubMed ID: 7467343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
    Bogaert MG; Rosseel MT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Duration of effects of isosorbide dinitrate retard in coronary disease].
    Raab C; Schindler J; Rahlfs VW
    Med Welt; 1977 Nov; 28(44):1807-9. PubMed ID: 593121
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 9. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) (author's transl)].
    Greif S; Roth F; Harnoncourt K
    Schweiz Rundsch Med Prax; 1977 Nov; 66(48):1554-9. PubMed ID: 337281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bioavailability of 2 different depot formulations with 40 mg of isosorbide dinitrate].
    Segre G; Zanolo G; Mondino A; Giachetti C; Silvestri S
    Fortschr Med; 1981 Dec; 99(47-48):2008-13. PubMed ID: 7327496
    [No Abstract]   [Full Text] [Related]  

  • 12. [The procedure for antianginal therapy with Isoket and nitrosorbide].
    Zhiliaev EV; Glazunov AV; Koroba GS
    Ter Arkh; 1992; 64(8):9-13. PubMed ID: 1440407
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dynamic ECG evaluation of the activity of long-acting isosorbide dinitrate in patients with unstable angina (author's transl)].
    Pedone V; Bellotti L; Belluzzi D; Di Biase G
    G Ital Cardiol; 1981; 11(10):1450-5. PubMed ID: 7042436
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV; Reddy KS; Wasir HS
    Indian Heart J; 1991; 43(2):97-100. PubMed ID: 1752623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the anti-angina effectiveness of gallopamil to isosorbide dinitrate in long-term medication].
    Kroesen P
    Med Welt; 1983 Dec; 34(50):1437-40. PubMed ID: 6420638
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the effects of depot isosorbide dinitrate (Isoket Retard 120) and diltiazem in patients with exertional angina pectoris].
    Meluzín J; Lupínek Z; Lupínková Z
    Vnitr Lek; 1990 Feb; 36(2):134-40. PubMed ID: 2186569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of isosorbide dinitrate and nitroglycerin in patients with angina pectoris].
    Zikmund M; Mayer O; Cepelák V
    Vnitr Lek; 1984 Nov; 30(11):1060-5. PubMed ID: 6440352
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
    Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the effectiveness of new delayed-action isosorbide dinitrate preparations in patients with exertion-induced stenocardia].
    Martsevich SIu; Metelitsa VI
    Klin Med (Mosk); 1986 Jun; 64(6):37-40. PubMed ID: 3747434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.